Table 3. Correlation between the clinicopathologic characteristics and expression of miR-616-5P in NSCLCs.

		miR-616-5p expression
Characteristics	n	Low	High	P value
Age (year)
<50	81	28 (34.6%)	53 (65.4%)	0.787
≥50	98	32 (32.7%)	66 (67.3%)
Gender
Male	123	38 (30.9%)	85 (69.1%)	0.183
Female	56	23 (41.1%)	33 (58.9%)
Clinical stage
I–II	108	66 (61.1%)	42 (38.9%)	<0.001
III–IV	71	16 (22.5%)	55 (77.5%)